Suven Life Sciences Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Sep ' 23	Sep ' 22	Mar ' 22	Sep ' 21	Sep ' 20

Sales

6.86

7.93

8.65

3.19

10.41

Operating profit

-14.87

-14.52

-14.48

-22.16

-11.63

Interest

0.09

0.17

0.23

0.30

0.47

Gross profit

-4.18

-14.04

-14.45

-17.41

-7.30

EPS (Rs)

-0.01

-0.77

-1.15

-1.53

-0.47

Other income

10.78

0.64

0.26

5.06

4.81

Stock adjustment

-

-

-

-

-

Raw material

-

-

-

-

-

Power and fuel

-

-

-

-

-

Employee expenses

8.75

8.56

9.16

8.30

8.27

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-14.87

14.87

11.97

Expenses capitalised

-

-

-

-

-

Other expenses

12.98

13.89

28.84

2.18

1.81

Provisions made

-

-

-

-

-

Depreciation

3.39

3.20

2.32

2.07

2.14

Taxation

-

-

-

-

-3.46

Net profit / loss

-0.12

-11.25

-16.77

-19.48

-5.98

Extra ordinary item

7.46

6.00

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

21.81

14.54

14.54

12.73

12.73

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

-216.85

-183.15

-167.32

-694.70

-111.77

GPM (%)

-23.71

-163.93

-162.10

-211.04

-47.98

NPM (%)

-0.66

-131.26

-188.18

-236.12

-39.29